Lance Alstodt, President, CEO, COB at BioRestorative Therapies, Inc. (BRTX), bought 200 shares at $2.99 ($584) on 2022-09-22, disclosed to the SEC on 2022-09-23.
Open-market purchase of $584 BRTX by President, CEO, COB. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 100 | $285 | 48.8% |
| 2 | $2.99 | 100 | $299 | 51.2% |
| Total | $2.92 avg | 200 | $584 | 100% |
| Filing → |
| BRTX | BUY | 2023-09-06 | $6K | — | Filing → |
| BRTX | BUY | 2023-07-25 | $10K | — | Filing → |
| BRTX | BUY | 2023-02-02 | $1K | — | Filing → |